Cargando…
Immunosuppressive agents for rheumatoid arthritis: a systematic review of clinical trials and their current development stage
AIMS: With the arrival of conventional synthetic (csDMARDs), biological (bDMARDS) and then targeted synthetic (tsDMARDs) disease-modifying anti-rheumatic drugs, the therapeutic arsenal against rheumatoid arthritis (RA) has recently expanded. However, there are still some unmet needs for patients who...
Autores principales: | Blaess, Julien, Walther, Julia, Petitdemange, Arthur, Gottenberg, Jacques-Eric, Sibilia, Jean, Arnaud, Laurent, Felten, Renaud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7747097/ https://www.ncbi.nlm.nih.gov/pubmed/33403019 http://dx.doi.org/10.1177/1759720X20959971 |
Ejemplares similares
-
Shared development of targeted therapies among autoimmune and inflammatory diseases: a systematic repurposing analysis
por: Petitdemange, Arthur, et al.
Publicado: (2020) -
Prescription strategy of antimalarials in cutaneous and systemic
lupus erythematosus: an international survey
por: Petitdemange, Arthur, et al.
Publicado: (2021) -
Effect of SARS-CoV-2 Vaccination on Symptoms from Post-Acute Sequelae of COVID-19: Results from the Nationwide VAXILONG Study
por: Scherlinger, Marc, et al.
Publicado: (2021) -
Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis
por: Alsaleh, Ghada, et al.
Publicado: (2010) -
miR-346 Controls Release of TNF-α Protein and Stability of Its mRNA in Rheumatoid Arthritis via Tristetraprolin Stabilization
por: Semaan, Noha, et al.
Publicado: (2011)